Literature DB >> 28425202

Examining solutions to missing data in longitudinal nursing research.

Mary B Roberts1, Mary C Sullivan2, Suzy B Winchester2.   

Abstract

PURPOSE: Longitudinal studies are highly valuable in pediatrics because they provide useful data about developmental patterns of child health and behavior over time. When data are missing, the value of the research is impacted. The study's purpose was to (1) introduce a three-step approach to assess and address missing data and (2) illustrate this approach using categorical and continuous-level variables from a longitudinal study of premature infants.
METHODS: A three-step approach with simulations was followed to assess the amount and pattern of missing data and to determine the most appropriate imputation method for the missing data. Patterns of missingness were Missing Completely at Random, Missing at Random, and Not Missing at Random. Missing continuous-level data were imputed using mean replacement, stochastic regression, multiple imputation, and fully conditional specification (FCS). Missing categorical-level data were imputed using last value carried forward, hot-decking, stochastic regression, and FCS. Simulations were used to evaluate these imputation methods under different patterns of missingness at different levels of missing data.
RESULTS: The rate of missingness was 16-23% for continuous variables and 1-28% for categorical variables. FCS imputation provided the least difference in mean and standard deviation estimates for continuous measures. FCS imputation was acceptable for categorical measures. Results obtained through simulation reinforced and confirmed these findings. PRACTICE IMPLICATIONS: Significant investments are made in the collection of longitudinal data. The prudent handling of missing data can protect these investments and potentially improve the scientific information contained in pediatric longitudinal studies.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  longitudinal research; methods; missing data

Mesh:

Year:  2017        PMID: 28425202      PMCID: PMC5419303          DOI: 10.1111/jspn.12179

Source DB:  PubMed          Journal:  J Spec Pediatr Nurs        ISSN: 1539-0136            Impact factor:   1.260


  17 in total

1.  How can I deal with missing data in my study?

Authors:  D A Bennett
Journal:  Aust N Z J Public Health       Date:  2001-10       Impact factor: 2.939

Review 2.  Multiple imputation: a primer.

Authors:  J L Schafer
Journal:  Stat Methods Med Res       Date:  1999-03       Impact factor: 3.021

3.  Best practices for missing data management in counseling psychology.

Authors:  Gabriel L Schlomer; Sheri Bauman; Noel A Card
Journal:  J Couns Psychol       Date:  2010-01

4.  Missing data in clinical studies: issues and methods.

Authors:  Joseph G Ibrahim; Haitao Chu; Ming-Hui Chen
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

5.  Missing data in longitudinal studies: cross-sectional multiple imputation provides similar estimates to full-information maximum likelihood.

Authors:  Mark A Ferro
Journal:  Ann Epidemiol       Date:  2013-10-18       Impact factor: 3.797

Review 6.  An introduction to modern missing data analyses.

Authors:  Amanda N Baraldi; Craig K Enders
Journal:  J Sch Psychol       Date:  2010-02

7.  Multiple imputation in a longitudinal cohort study: a case study of sensitivity to imputation methods.

Authors:  Helena Romaniuk; George C Patton; John B Carlin
Journal:  Am J Epidemiol       Date:  2014-10-09       Impact factor: 4.897

8.  Analytical results in longitudinal studies depended on target of inference and assumed mechanism of attrition.

Authors:  Mark Jones; Gita D Mishra; Annette Dobson
Journal:  J Clin Epidemiol       Date:  2015-03-31       Impact factor: 6.437

9.  Multiple imputation using chained equations: Issues and guidance for practice.

Authors:  Ian R White; Patrick Royston; Angela M Wood
Journal:  Stat Med       Date:  2010-11-30       Impact factor: 2.373

10.  A 'missing not at random' (MNAR) and 'missing at random' (MAR) growth model comparison with a buprenorphine/naloxone clinical trial.

Authors:  Sterling McPherson; Celestina Barbosa-Leiker; Mary Rose Mamey; Michael McDonell; Craig K Enders; John Roll
Journal:  Addiction       Date:  2014-10-16       Impact factor: 6.526

View more
  3 in total

1.  Identification of a Cascade of Changes in Activities of Daily Living Preceding Short-Term Clinical Deterioration in Mild Alzheimer's Disease Dementia via Lead-Lag Analysis.

Authors:  Manuel Fuentes; Arne Klostermann; Luca Kleineidam; Chris Bauer; Johannes Schuchhardt; Wolfgang Maier; Frank Jessen; Lutz Frölich; Jens Wiltfang; Johannes Kornhuber; Stefan Klöppel; Vera Schieting; Stefan J Teipel; Michael Wagner; Oliver Peters
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  An Economic Evaluation Supported by Qualitative Data About the Patient Concerns Inventory (PCI) versus Standard Treatment Pathway in the Management of Patients with Head and Neck Cancer.

Authors:  Victory 'Segun Ezeofor; Llinos Haf Spencer; Simon N Rogers; Anastasios Kanatas; Derek Lowe; Cherith J Semple; Jeffrey R Hanna; Seow Tien Yeo; Rhiannon Tudor Edwards
Journal:  Pharmacoecon Open       Date:  2022-01-31

3.  Prediction of all-cause mortality from 24 month trajectories in patient-reported psychological, clinical and quality of life outcomes in uveal melanoma patients.

Authors:  Stephen L Brown; Peter L Fisher; Laura Hope-Stone; Heinrich Heimann; Rumana Hussain; M Gemma Cherry
Journal:  J Behav Med       Date:  2021-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.